KR20010015607A - 포스폴암밴 억제자로서 1-옥사, 아자 및티아나프탈렌-2-온의 비스에테르 - Google Patents
포스폴암밴 억제자로서 1-옥사, 아자 및티아나프탈렌-2-온의 비스에테르 Download PDFInfo
- Publication number
- KR20010015607A KR20010015607A KR1020007003094A KR20007003094A KR20010015607A KR 20010015607 A KR20010015607 A KR 20010015607A KR 1020007003094 A KR1020007003094 A KR 1020007003094A KR 20007003094 A KR20007003094 A KR 20007003094A KR 20010015607 A KR20010015607 A KR 20010015607A
- Authority
- KR
- South Korea
- Prior art keywords
- alkyl
- aryl
- arylalkyl
- hydrogen
- compound
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/20—Oxygen atoms
- C07D215/22—Oxygen atoms attached in position 2 or 4
- C07D215/227—Oxygen atoms attached in position 2 or 4 only one oxygen atom which is attached in position 2
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/06—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2
- C07D311/08—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring
- C07D311/16—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 2 not hydrogenated in the hetero ring substituted in position 7
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
- C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
- C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
- C07D311/58—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring other than with oxygen or sulphur atoms in position 2 or 4
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- General Chemical & Material Sciences (AREA)
- Cardiology (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Urology & Nephrology (AREA)
- Vascular Medicine (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Quinoline Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (7)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US93711997A | 1997-09-24 | 1997-09-24 | |
| US937119 | 1997-09-24 | ||
| US99015097A | 1997-12-12 | 1997-12-12 | |
| US990150 | 1997-12-12 | ||
| US10411498A | 1998-06-25 | 1998-06-25 | |
| US104114 | 1998-06-25 | ||
| PCT/FI1998/000755 WO1999015523A1 (fr) | 1997-09-24 | 1998-09-24 | Bisethers de 1-oxa, aza et thianaphtalene-2-one inhibiteurs du phospholambane |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| KR20010015607A true KR20010015607A (ko) | 2001-02-26 |
Family
ID=27379660
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| KR1020007003094A KR20010015607A (ko) | 1997-09-24 | 1998-09-24 | 포스폴암밴 억제자로서 1-옥사, 아자 및티아나프탈렌-2-온의 비스에테르 |
Country Status (18)
| Country | Link |
|---|---|
| EP (1) | EP1017691A1 (fr) |
| JP (1) | JP2003525838A (fr) |
| KR (1) | KR20010015607A (fr) |
| CN (1) | CN1143857C (fr) |
| AU (1) | AU735729B2 (fr) |
| BR (1) | BR9813216A (fr) |
| CA (1) | CA2304849A1 (fr) |
| EA (1) | EA003084B1 (fr) |
| EE (1) | EE04494B1 (fr) |
| HU (1) | HUP0003647A3 (fr) |
| ID (1) | ID24373A (fr) |
| IL (1) | IL134662A0 (fr) |
| NO (1) | NO20001569L (fr) |
| NZ (1) | NZ503044A (fr) |
| PL (1) | PL339493A1 (fr) |
| SK (1) | SK3902000A3 (fr) |
| TR (1) | TR200000764T2 (fr) |
| WO (1) | WO1999015523A1 (fr) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7026491B2 (en) | 2000-07-21 | 2006-04-11 | Chugai Seiyaku Kabushiki Kaisha | Coumarin derivatives useful as TNFα inhibitors |
| AU2002226634B2 (en) * | 2001-03-30 | 2007-01-25 | Pfizer Products Inc. | Pyridazinone aldose reductase inhibitors |
| US7572910B2 (en) | 2003-02-20 | 2009-08-11 | Pfizer, Inc. | Pyridazinone aldose reductase inhibitors |
| FR2970964B1 (fr) * | 2011-01-28 | 2013-12-13 | Univ Claude Bernard Lyon | Nouveaux derives d'azacoumarines presentant une activite inhibitrice des pompes mdr |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE2543945A1 (de) * | 1975-10-02 | 1977-04-21 | Troponwerke Gmbh & Co Kg | 2-benzopyranonderivate, verfahren zu ihrer herstellung sowie ihre verwendung als arzneimittel |
| GB8529362D0 (en) * | 1985-11-28 | 1986-01-02 | Pfizer Ltd | Quinolone cardiac stimulants |
| GB8630702D0 (en) * | 1986-12-23 | 1987-02-04 | Wellcome Found | Quinoline compound |
| DK391189A (da) * | 1988-08-10 | 1990-02-11 | Otsuka Pharma Co Ltd | Carbostyrilderivater |
| CA2022236A1 (fr) * | 1989-07-31 | 1991-02-01 | Hiroaki Yanagisawa | Derives de coumarin, leur preparation et leur utilisation pour le traitement des troubles cerebrovasculaires |
| DE4337906A1 (de) * | 1993-11-08 | 1995-05-11 | Cassella Ag | Verwendung von Cumarinderivaten |
-
1998
- 1998-09-24 ID IDW20000564A patent/ID24373A/id unknown
- 1998-09-24 AU AU93508/98A patent/AU735729B2/en not_active Ceased
- 1998-09-24 CA CA002304849A patent/CA2304849A1/fr not_active Abandoned
- 1998-09-24 TR TR2000/00764T patent/TR200000764T2/xx unknown
- 1998-09-24 KR KR1020007003094A patent/KR20010015607A/ko not_active Application Discontinuation
- 1998-09-24 PL PL98339493A patent/PL339493A1/xx unknown
- 1998-09-24 EE EEP200000179A patent/EE04494B1/xx not_active IP Right Cessation
- 1998-09-24 EA EA200000352A patent/EA003084B1/ru not_active IP Right Cessation
- 1998-09-24 NZ NZ503044A patent/NZ503044A/en unknown
- 1998-09-24 HU HU0003647A patent/HUP0003647A3/hu unknown
- 1998-09-24 EP EP98946482A patent/EP1017691A1/fr not_active Withdrawn
- 1998-09-24 JP JP2000512828A patent/JP2003525838A/ja active Pending
- 1998-09-24 CN CNB98809438XA patent/CN1143857C/zh not_active Expired - Fee Related
- 1998-09-24 SK SK390-2000A patent/SK3902000A3/sk unknown
- 1998-09-24 IL IL13466298A patent/IL134662A0/xx unknown
- 1998-09-24 BR BR9813216-4A patent/BR9813216A/pt not_active IP Right Cessation
- 1998-09-24 WO PCT/FI1998/000755 patent/WO1999015523A1/fr not_active Application Discontinuation
-
2000
- 2000-03-24 NO NO20001569A patent/NO20001569L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| BR9813216A (pt) | 2000-08-29 |
| AU9350898A (en) | 1999-04-12 |
| EE04494B1 (et) | 2005-06-15 |
| CN1271357A (zh) | 2000-10-25 |
| EE200000179A (et) | 2001-04-16 |
| PL339493A1 (en) | 2000-12-18 |
| HUP0003647A2 (hu) | 2001-08-28 |
| ID24373A (id) | 2000-07-13 |
| CN1143857C (zh) | 2004-03-31 |
| EA003084B1 (ru) | 2002-12-26 |
| TR200000764T2 (tr) | 2001-03-21 |
| HUP0003647A3 (en) | 2002-12-28 |
| IL134662A0 (en) | 2001-04-30 |
| AU735729B2 (en) | 2001-07-12 |
| JP2003525838A (ja) | 2003-09-02 |
| NO20001569D0 (no) | 2000-03-24 |
| NO20001569L (no) | 2000-03-24 |
| NZ503044A (en) | 2001-08-31 |
| EP1017691A1 (fr) | 2000-07-12 |
| CA2304849A1 (fr) | 1999-04-01 |
| SK3902000A3 (en) | 2000-12-11 |
| WO1999015523A1 (fr) | 1999-04-01 |
| EA200000352A1 (ru) | 2000-10-30 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2001502318A (ja) | 心臓血管系および中枢神経系の特定疾病を治療するための縮合（ヘタリール置換）１―ベンジル―３―ピラゾール誘導体の使用 | |
| EP1039884B1 (fr) | Methode de prevention et de traitement de la sideration myocardique | |
| RU2282627C2 (ru) | Кумариновые производные с подавляющей комт активностью | |
| US6265421B1 (en) | Phospholamban inhibitors and a method for increasing coronary flow | |
| AU2001272597A1 (en) | Coumarin derivatives with COMT inhibiting activity | |
| KR20010015607A (ko) | 포스폴암밴 억제자로서 1-옥사, 아자 및티아나프탈렌-2-온의 비스에테르 | |
| BG65859B1 (bg) | Пиридазинил фенил хидразони, полезни срещу конгестивна сърдечна недостатъчност | |
| EP1001774B1 (fr) | Utilisation d'inhibiteurs de phospholamban pour augmenter le debit coronaire | |
| US5545660A (en) | Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans | |
| JP3226174B2 (ja) | ３，４−ジヒドロ−２ｈ−１−ベンゾピラン類のヒドラジド誘導体類 | |
| MXPA00002954A (en) | Bisethers of 1-oxa, aza and thianaphthalen-2-ones as phospholamban inhibitors | |
| CZ2000937A3 (cs) | Bisethery 1-oxa, aza a thianaftalen-2-onu jako inhibitory fosfolambanu a farmaceutické prostředky | |
| WO2012069620A1 (fr) | Donneurs d'oxyde nitrique dans la thérapie de troubles de la microcirculation cérébrale induits par une déficience en oxyde nitrique |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| A201 | Request for examination | ||
| E902 | Notification of reason for refusal | ||
| E601 | Decision to refuse application |